Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000800325
Ethics application status
Approved
Date submitted
15/08/2015
Date registered
31/05/2017
Date last updated
6/05/2019
Date data sharing statement initially provided
6/05/2019
Type of registration
Retrospectively registered

Titles & IDs
Public title
Clinical evaluation of a novel suture anchor for rotator cuff repairs – ATOK Anchor
Scientific title
Evaluation of a novel suture anchor compared to a historical controls on repair integity and function in patients with rotator cuff tear.
Secondary ID [1] 287285 0
nil known
Universal Trial Number (UTN)
U1111-1173-2414
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Patients over the age of 60, with a less than 3cm rotator cuff tear involving the supraspinatus and at least part of the infraspinatus tendons. Patients will have failed non-operative management. 295919 0
Condition category
Condition code
Surgery 296171 296171 0 0
Surgical techniques
Musculoskeletal 296253 296253 0 0
Other muscular and skeletal disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Repair of rotator cuff tear using an arthroscopic technique, utilizing a new anchor to secure the transosseous sutures to the lateral humeral cortex.
The repair will idealy performed using an arthroscopic however a mini-open approach may be utilised if there is inadequate visualisation, or concerns about seating of the implant.
The novel anchor to be used is the Arthroscopic Trans-Osseous Knotless (ATOK) anchor. Generally 2 anchors are used. The procedure will be performed under a general anaesthetic and by an orthopaedic surgeon, who is the principal investigator.
The procedure is anticipate to take between 30 and 60 minutes and will where appropriate be combined with an acromioplasty, or lateral clavicle excision.
The anchor is inserted percutaneously through the lateral arm muscle and into the humeral cortex. The suture are passed and secured using the locking plug.
There are no exactly similar studies on such a challenging group of patients, however, changes in outcome scores and displacement of anchors based on MRI review are the critical review end points.
The patients will undergo the surgery between July 2015 and July 2016, with assessment of anchor position at 1 and 6 months, tendon healing at 6 months, and functional outcomes progressively from 3 months out to 2 years.
Intervention code [1] 298199 0
Treatment: Devices
Intervention code [2] 298227 0
Treatment: Surgery
Comparator / control treatment
Comparison controls will be with previously publlished series and relates to rupture and re-tear rate as well as functional outcomes.
The most relevent comparator published study is:
Boileau P, Brassart N, Watkinson DJ, Carles M, Hatzidakis AM, Krishnan SG. Arthroscopic repair of full-thickness tears of the supraspinatus: does the tendon really heal? J Bone Joint Surg Am. 2005;87:1229–1240.

The initial study aim is to assess safety and general efficacy, but without the precision to compare to an alternate technique.
The comparator is a benchmark study using arthroscopic repairs using standard techniques and a variety of anchors. The outcomes are generally favourable using existing anchors, however, the new anchor aims to address difficult patients where the proximal humeral bone is quite osteoporotic and prone to lead to pull out of currently used anchors.
There are no exactly similar studies on such a challenging group of patients, however, changes in outcome scores and displacement of anchors based on MRI review are the critical review end points.

Historical controls will those gleaned from published data which most closely matches the patient group. There are not truly comparative cohort.
Control group
Historical

Outcomes
Primary outcome [1] 295843 0
Repair of rotator cuff tear, assessed by MRI; timepoint- 6 months post surgery.
Timepoint [1] 295843 0
6 months
Primary outcome [2] 295910 0
Shoulder function, assessed on Constant, Oxford Shoulder Score
Timepoint [2] 295910 0
6 and 12 months post surgery.
Primary outcome [3] 295911 0
Non-displacement of ATOK anchors as identified on MRI
Timepoint [3] 295911 0
one month and 6 months post surgery
Secondary outcome [1] 316711 0
Functional outcome based on Constant and Oxford Sholder score
Timepoint [1] 316711 0
2 years post surgery

Eligibility
Key inclusion criteria
Patients with rotator cuff tears, less than 3cm, and over 60 years of age.
Failed 3 months of of targeted conservative therapy.
These patients are likely to have osteoporosis of the proximal humerus, but such bone changes will not be quantified.
Minimum age
60 Years
Maximum age
80 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Arthritis of the shoulder
Unable to understand the trial due to language or comprehension
Significant loss of motion

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Phase 1
Type of endpoint/s
Statistical methods / analysis
The number of participants was determined on the number of potential patients likely to be recruited over a 12 month period.
This is a pilot study to assess anchor integrity and potential for displacement as well as ability to achieve rotator cuff healing at a rate, at least as good as existing published results.
Sample size calculation was not formally performed. Once 20 patients have been recruited and followed for 12 months, a formal comparative trial will be considered.
At any stage if there is displacement of the anchors, the trial is likely to be terminated, unless there are reasons for the failure can be reasonable explained, such as technical error, or additional trauma.
Pre and 6, 12 and 24 month functional outcomes will be statistically compared.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
3/06/2015
Date of last participant enrolment
Anticipated
1/07/2017
Actual
1/05/2018
Date of last data collection
Anticipated
1/05/2018
Actual
1/05/2018
Sample size
Target
20
Accrual to date
Final
15
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 4197 0
Calvary Wakefield Hospital - Adelaide
Recruitment hospital [2] 4198 0
Parkwynd Private Hospital - Adelaide
Recruitment hospital [3] 4199 0
St Andrew's Hospital Inc - Adelaide
Recruitment postcode(s) [1] 10110 0
5000 - Adelaide

Funding & Sponsors
Funding source category [1] 291841 0
Commercial sector/Industry
Name [1] 291841 0
Wright Medical
Country [1] 291841 0
Australia
Primary sponsor type
Individual
Name
Assoc Prof Michael Sandow
Address
Wakefield Orthopaedic Clinic
270 Wakefield Street,
Adelaide
SA 5000
Country
Australia
Secondary sponsor category [1] 290509 0
Commercial sector/Industry
Name [1] 290509 0
Macropace Products Pty Ltd
Address [1] 290509 0
14 Hauteville Terrace
Eastwood SA 5063
Country [1] 290509 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 293358 0
Human Research Ethics Committee, Royal Adelaide Hospital
Ethics committee address [1] 293358 0
Royal Adelaide Hospital :-
Level 4, Women’s Health Centre, Royal Adelaide Hospital
North Terrace, Adelaide SA 5000
Ethics committee country [1] 293358 0
Australia
Date submitted for ethics approval [1] 293358 0
10/04/2015
Approval date [1] 293358 0
27/04/2015
Ethics approval number [1] 293358 0
HREC/15/RAH/40

Summary
Brief summary
Purpose of study to investigate the safety and efficacy of a novel attempt to achieve trans osseous repair of disrupted or torn rotator cuff using the knotless technique.

This is essentially a safety and efficacy trial to confirm the biomechanical advantages in a clinical setting of the recently designed arthroscopic trans-osseous knotless technique using an ATOK implant.
Trial website
nil
Trial related presentations / publications
Public notes
Attachments [1] 540 540 0 0
/AnzctrAttachments/369127-ANZORS Abstract_CFJ_21June2014.pdf

Contacts
Principal investigator
Name 59566 0
A/Prof Michael Sandow FRACS
Address 59566 0
Wakefield Orthopaedic Clinic
270 Wakefield Street
Adelaide
Adelaide
SA 5000
Country 59566 0
Australia
Phone 59566 0
+61 8 8236 4166
Fax 59566 0
Email 59566 0
[email protected]
Contact person for public queries
Name 59567 0
Michael Sandow FRACS
Address 59567 0
Wakefield Orthopaedic Clinic
270 Wakefield Street
Adelaide
Adelaide
SA 5000
Country 59567 0
Australia
Phone 59567 0
+61 8 8236 4166
Fax 59567 0
Email 59567 0
[email protected]
Contact person for scientific queries
Name 59568 0
Michael Sandow FRACS
Address 59568 0
Wakefield Orthopaedic Clinic
270 Wakefield Street
Adelaide
SA 5000
Country 59568 0
Australia
Phone 59568 0
+61 8 8236 4166
Fax 59568 0
Email 59568 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Confidentially stored


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.